Multiple sclerosis (MS)
50 results
1 - 50
Multiple sclerosis (MS) - Spasticity
- Cyclophosphamide for multiple sclerosis
- Psychological interventions for multiple sclerosis
- Polyunsaturated fatty acids for multiple sclerosis
- Interferon beta for secondary progressive multiple sclerosis
- Lumbar puncture
- Recombinant interferon beta for delaying conversion of the first demyelinating event to multiple sclerosis
- Teriflunomide for multiple sclerosis
- Amantadine for fatigue in multiple sclerosis
- List of abbreviations
- Mitoxantrone for multiple sclerosis
- Impaired vision
- Exercise therapy for multiple sclerosis
- Episodic attacks of flushing
- Alemtuzumab for multiple sclerosis
- Non-pharmacological interventions for spasticity in multiple sclerosis
- Oral versus intravenous steroids for treatment of relapses in multiple sclerosis
- Glatiramer acetate for multiple sclerosis
- Multidisciplinary rehabilitation for adults with multiple sclerosis
- Corticosteroids for the long-term treatment in multiple sclerosis
- Obstipation in the adult
- Diseases of the spinal cord
- Dyspnoea
- Pharmacologic treatment for memory disorder in multiple sclerosis
- Neuropsychological rehabilitation for multiple sclerosis
- Memory rehabilitation in multiple sclerosis
- Lumbar spinal stenosis (LSS)
- Eye symptoms and signs of systemic diseases
- Fatigue
- Burning mouth and glossalgia
- Benign paroxysmal positional vertigo (BPPV)
- Ataxia
- Immunomodulators and immunosuppressants for relapsing-remitting multiple sclerosis (RRMS): a network meta-analysis
- Raynaud's phenomenon (RP) or white finger disease
- Gait disturbances
- Muscle weakness and paralysis symptom
- Primary Sjögren's syndrome
- Vertigo
- Pruritus
- Trigeminal neuralgia and other facial pain
- Lyme borreliosis (LB)